SCHEMBL23736100

SCHEMBL23736100

COCCOCCN1c2ccc(C(C)(C)C)cc2Sc2cc(C(C)(C)C)ccc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FPR2 P25090 7/20 0.45
KDM4E B2RXH2 3/20 0.39
ALDH1A1 P00352 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
RECQL P46063 1/20 0.35
TP53 P04637 4/20 0.35
MAPK1 P28482 3/20 0.35
LMNA P02545 3/20 0.35
MAPT P10636 3/20 0.35
NPC1 O15118 2/20 0.35
CYP1A2 P05177 2/20 0.35
ABCB1 P08183 2/20 0.35
HTR1A P08908 2/20 0.35
ADRA2A P08913 2/20 0.35
ADORA3 P0DMS8 2/20 0.35
CYP2D6 P10635 2/20 0.35
CHRM1 P11229 2/20 0.35
TSHR P16473 2/20 0.35
DRD1 P21728 2/20 0.35
SLC6A2 P23975 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23736096 0.92 TP53 (0.37) FPR2KDM4EALDH1A1SMN1; SMN2TP53
SCHEMBL17359358 0.89 FPR2 (0.54) FPR2KDM4EALDH1A1SMN1; SMN2RECQL
SCHEMBL17356852 0.84 FPR2 (0.50) FPR2KDM4EALDH1A1SMN1; SMN2RECQL
SCHEMBL19897085 0.81 SNCA (0.50) FPR2KDM4EALDH1A1TP53MAPK1
SCHEMBL19897039 0.81 DRD2 (0.49) FPR2KDM4EALDH1A1SMN1; SMN2TP53
SCHEMBL17359352 0.80 TP53 (0.48) FPR2KDM4EALDH1A1SMN1; SMN2RECQL
SCHEMBL29935425 0.80 KDM4E (0.40) FPR2KDM4EALDH1A1SMN1; SMN2RECQL
SCHEMBL23736095 0.79 KDM4E (0.38) FPR2KDM4EALDH1A1SMN1; SMN2RECQL
SCHEMBL23736099 0.78 TP53 (0.35) FPR2KDM4EALDH1A1SMN1; SMN2RECQL
SCHEMBL18890496 0.77 KDM1A (0.53) FPR2KDM4EALDH1A1SMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11094964-B2 Rechargeable electrochemical cell BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2021-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11094964-B2 Rechargeable electrochemical cell NES, SLC25A13, HCN2 FPR2 4544/4885KDM4E 3133/4885ALDH1A1 2472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.